Lumicell

About:

Lumicell is a biotechnology company that develops and markets image-guided cancer surgery solutions.

Website: http://lumicell.com

Twitter/X: LumicellSurg

Top Investors: National Science Foundation, LaunchCapital, Kodiak Venture Partners, Intuitive Venture Partners, Rivas Capital

Description:

Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, is currently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated. Lumicell was founded in 2008 and is based in Newton, MA, USA.